Latest News about VCYT
Recent news which mentions VCYT
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 10, 2021
May 10, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
From Benzinga
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
May 07, 2021
From Benzinga
54 Biggest Movers From Friday
April 19, 2021
From Benzinga
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
April 16, 2021
From Benzinga
3 Cancer Diagnostic Monster Stocks on Sale
April 03, 2021
From Motley Fool
Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath
April 01, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
From Benzinga
Earnings Scheduled For February 17, 2021
February 17, 2021
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 09, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
February 05, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
Veracyte Raises $550M In Upsized Equity Offering For Decipher Biosciences Acquisition
February 05, 2021
Tickers
VCYT
From Benzinga
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
Veracyte Seeks To Raise $400M To Fund Decipher Biosciences Deal
February 04, 2021
Tickers
VCYT
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 03, 2021
From Benzinga
Veracyte Scoops Up Decipher Biosciences For $600M, Reports Fourth Quarter Interim Results
February 03, 2021
Tickers
VCYT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.